| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
AIDS-Related Mycobacterium kansasii Infection with Initial Resistance to Clarithromycin
|
Burman, William J
|
|
1998
|
31 |
2 |
p. 369-371
3 p.
|
artikel
|
| 2 |
Bacterial Resistance: A Worldwide Problem
|
Jones, Ronald N.
|
|
1998
|
31 |
2 |
p. 379-388
10 p.
|
artikel
|
| 3 |
Clinical Strategies for Serious Infection: A European Perspective
|
Garau, Javier
|
|
1998
|
31 |
2 |
p. 397-404
8 p.
|
artikel
|
| 4 |
Clinical Strategies for Serious Infection: A North American Perspective
|
Quinn, JohnP
|
|
1998
|
31 |
2 |
p. 389-395
7 p.
|
artikel
|
| 5 |
Combinations of Orally Administered β-Lactams to Maximize Spectrum and Activity against Drug-resistant Respiratory Tract Pathogens: I. Synergy Studies of Amoxicillin and Cefixime with Streptococcus pneumoniae
|
Jones, RonaldN
|
|
1998
|
31 |
2 |
p. 373-376
4 p.
|
artikel
|
| 6 |
Comparative Antimicrobial Activity and Kill-Curve Investigations of Novel Ketolide Antimicrobial Agents (HMR 3004 and HMR 3647) Tested against Haemophilus influenzae and Moraxella catarrhalis Strains
|
Biedenbach, Douglas J
|
|
1998
|
31 |
2 |
p. 349-353
5 p.
|
artikel
|
| 7 |
Comparison of Six Rapid Agglutination Tests for the Identification of Staphylococcus aureus, Including Methicillin-resistant Strains
|
Gupta, Hema
|
|
1998
|
31 |
2 |
p. 333-336
4 p.
|
artikel
|
| 8 |
Editorial
|
|
|
1998
|
31 |
2 |
p. 377-
1 p.
|
artikel
|
| 9 |
Expanding the Options for Risk-based Therapy in Febrile Neutropenia
|
Rolston, Kenneth V.
|
|
1998
|
31 |
2 |
p. 411-416
6 p.
|
artikel
|
| 10 |
In Vitro Activities of Six Fluoroquinolones against Canadian Isolates of Vancomycin-sensitive and Vancomycin-resistant Enterococcus species
|
Zhanel, George G.
|
|
1998
|
31 |
2 |
p. 343-347
5 p.
|
artikel
|
| 11 |
Optimal Recovery of Cytomegalovirus from Urine as a Function of Specimen Preparation
|
Bennion, Debra W
|
|
1998
|
31 |
2 |
p. 337-342
6 p.
|
artikel
|
| 12 |
Piperacillin/Tazobactam versus Imipenem: A Double-Blind, Randomized Formulary Feasibility Study at a Major Teaching Hospital 1 1 At the time of the study, FM was an Infectious Diseases Pharmacotherapeutics Fellow.
|
Marra, Fawziah
|
|
1998
|
31 |
2 |
p. 355-368
14 p.
|
artikel
|
| 13 |
Selecting Therapy for Serious Infections in Children: Maximizing Safety and Efficacy
|
Bradley, John S
|
|
1998
|
31 |
2 |
p. 405-410
6 p.
|
artikel
|
Tijdschrift beschrijving